83 related articles for article (PubMed ID: 15375377)
21. Genetic and epigenetic changes in p21 and p21B do not correlate with resistance to doxorubicin or mitomycin and 5-fluorouracil in locally advanced breast cancer.
Staalesen V; Leirvaag B; Lillehaug JR; Lønning PE
Clin Cancer Res; 2004 May; 10(10):3438-43. PubMed ID: 15161699
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
Kami K; Doi R; Koizumi M; Toyoda E; Mori T; Ito D; Kawaguchi Y; Fujimoto K; Wada M; Miyatake S; Imamura M
Surgery; 2005 Aug; 138(2):299-305. PubMed ID: 16153440
[TBL] [Abstract][Full Text] [Related]
23. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
24. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.
Myrthue A; Rademacher BL; Pittsenbarger J; Kutyba-Brooks B; Gantner M; Qian DZ; Beer TM
Clin Cancer Res; 2008 Jun; 14(11):3562-70. PubMed ID: 18519790
[TBL] [Abstract][Full Text] [Related]
25. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
26. [Effects of Her-2/neu siRNA-mediated gene silencing on cell cycle and apoptosis of lung adenocarcinoma cells].
Ren SH; Wang JW; Zhang L
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1530-4. PubMed ID: 16179111
[TBL] [Abstract][Full Text] [Related]
27. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
[TBL] [Abstract][Full Text] [Related]
28. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
[TBL] [Abstract][Full Text] [Related]
29. Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilms tumor 1 gene.
Navakanit R; Graidist P; Leeanansaksiri W; Dechsukum C
J Med Assoc Thai; 2007 Nov; 90(11):2416-21. PubMed ID: 18181329
[TBL] [Abstract][Full Text] [Related]
30. Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene.
Crnkovic-Mertens I; Hoppe-Seyler F; Butz K
Oncogene; 2003 Nov; 22(51):8330-6. PubMed ID: 14614456
[TBL] [Abstract][Full Text] [Related]
31. Bcl-2 targeting siRNA expressed by a T7 vector system inhibits human tumor cell growth in vitro.
Holle L; Hicks L; Song W; Holle E; Wagner T; Yu X
Int J Oncol; 2004 Mar; 24(3):615-21. PubMed ID: 14767546
[TBL] [Abstract][Full Text] [Related]
32. Silencing of c-myc expression in tumor cells by siRNA.
Kabilova TO; Chernolovskaya EL; Vladimirova AV; Vlassov VV
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):867-72. PubMed ID: 15560074
[TBL] [Abstract][Full Text] [Related]
33. Curtailing overexpression of E2F3 in breast cancer using siRNA (E2F3)-based gene silencing.
Vimala K; Sundarraj S; Sujitha MV; Kannan S
Arch Med Res; 2012 Aug; 43(6):415-22. PubMed ID: 22960857
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer.
Yang Y; Hu Y; Wang Y; Li J; Liu F; Huang L
Mol Pharm; 2012 Aug; 9(8):2280-9. PubMed ID: 22686936
[TBL] [Abstract][Full Text] [Related]
35. siRNA agents inhibit oncogene expression and attenuate human tumor cell growth.
Yin JQ; Gao J; Shao R; Tian WN; Wang J; Wan Y
J Exp Ther Oncol; 2003; 3(4):194-204. PubMed ID: 14567290
[TBL] [Abstract][Full Text] [Related]
36. Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro.
Pirayesh Islamian J; Mohammadi M; Baradaran B; Farajollahi A; Aghamiri SM; Asghari Jafarabadi M; Karami H; Monfaredan A; Shanehbandi D
Bioimpacts; 2016; 6(2):93-8. PubMed ID: 27525226
[TBL] [Abstract][Full Text] [Related]
37. siRNA and targeted delivery systems in breast cancer therapy.
Mirzaei S; Paskeh MDA; Entezari M; Bidooki SH; Ghaleh VJ; Rezaei S; Hejazi ES; Kakavand A; Behroozaghdam M; Movafagh A; Taheriazam A; Hashemi M; Samarghandian S
Clin Transl Oncol; 2023 May; 25(5):1167-1188. PubMed ID: 36562927
[TBL] [Abstract][Full Text] [Related]
38. A database of breast oncogenic specific siRNAs.
Tyagi A; Semwal M; Sharma A
Sci Rep; 2017 Aug; 7(1):8706. PubMed ID: 28821760
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetics of human breast cancer.
McKenzie K; Sukumar S
Prog Clin Biol Res; 1996; 394():183-209. PubMed ID: 8778797
[No Abstract] [Full Text] [Related]
40. Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer.
Tekedereli I; Alpay SN; Akar U; Yuca E; Ayugo-Rodriguez C; Han HD; Sood AK; Lopez-Berestein G; Ozpolat B
Mol Ther Nucleic Acids; 2013 Sep; 2(9):e121. PubMed ID: 24022053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
